New Delhi: Canon Medical Systems India has signed a research collaboration agreement with Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) to study the role of advanced CT imaging and artificial intelligence (AI) in cancer diagnostics. Under the agreement, RGCIRC will use Canon’s Aquilion ONE / INSIGHT Edition, a 640-slice CT scanner, for research into oncology applications. The system integrates deep learning-based AI to enhance image sharpness, automate scan planning, and reduce radiation dosage, while offering wide-area (16-cm) CT coverage. It features the Precise IQ Engine (PIQE) for sharper imaging, the Advanced intelligent Clear-IQ Engine (AiCE) with SilverBeam filter for dose reduction, and the INSTINX platform for AI-assisted workflow support.
The collaboration is designed to generate research insights on how AI-driven CT imaging can improve diagnostic accuracy and efficiency in cancer care. Leaders from both institutions emphasized the research potential of the partnership. Koh Yamada, President and CEO of Canon Medical Systems India, said the agreement reflects the company’s approach to supporting healthcare institutions in advancing diagnostic capabilities.
Dr. Sudhir Rawal, Medical Director and Director of Surgical Oncology at RGCIRC, noted that the institute continues to invest in advanced technologies to strengthen cancer research and treatment. Dr. Sunil Kumar Puri, Director of Radiology and Interventional Oncology at RGCIRC, added that the institute, as the first in India to deploy this system, expects the collaboration to contribute to improved diagnostic confidence and patient outcomes. This initiative highlights the growing role of AI-enabled imaging in oncology research, reflecting broader trends in India’s healthcare sector.
